<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        39-82-01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VAQTA VACCINE 50 U VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HEPATITIS A VIRUS
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        IU/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suspension for injection in pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        114
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MERCK SHARP AND DOHME LLC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MERCK SHARP AND DOHME LLC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MERCK SHARP & DOHME
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J07BC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Vaqta Adult is one of a general group of medicines called vaccines. Vaccines are used to protect against infectious diseases. They work by causing the body to produce its own protection against the targeted disease.</p><p>&nbsp;</p><p>This vaccine helps to protect against hepatitis A infection.</p><p>&nbsp;</p><p>Hepatitis A is a virus that attacks the liver, which can be caught from food or drink that contains the virus. Symptoms of hepatitis A include a yellowing of the skin and eyes (jaundice) and feeling generally unwell.</p><p>&nbsp;</p><p>When an injection of this vaccine is given, the body&#39;s natural defences will produce protection (antibodies) against the hepatitis A infection. However, it usually takes 2 to 4 weeks after receiving the injection before you will be protected.</p><p>&nbsp;</p><p>This vaccine will not protect you against other viruses that infect the liver (such as hepatitis B, hepatitis C or hepatitis E). This vaccine protects against hepatitis A but cannot cause hepatitis A infection.</p><p>&nbsp;</p><p>The vaccination may not work properly if the person to be vaccinated is already infected with the hepatitis A virus.</p><p>&nbsp;</p><p>Vaqta Adult is for adults aged 18 years and over. This vaccine is not suitable for anyone younger than 18 years of age.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]-->1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not use Vaqta Adult:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you are allergic to the active substance or any of the other ingredients of Vaqta Adult (listed in section 6) or to neomycin or formaldehyde (see section &quot;Warnings and precautions&quot;).</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you are ill with a high temperature. The vaccination should be delayed until you have recovered.</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor, pharmacist or nurse before Vaqta Adult is given:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you have ever had an allergic reaction to a previous dose of Vaqta Adult. This vaccine may contain traces of an antibiotic called neomycin and a substance called formaldehyde, both of which are used during vaccine production and may be present in the vaccine in trace amounts.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you have a poor or reduced immune system, due to:</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->corticosteroids, cytotoxic drugs or radiotherapy. Your doctor or nurse may wait until the treatment has finished.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->HIV (human immunodeficiency virus infection) or any disease that affects the immune system. The vaccine may not protect as well as it protects people whose immune system is healthy.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you have any problems with the blood that causes easy bruising or bleeding for a long time after minor cuts. Your doctor or nurse may still advise that you should have Vaqta Adult but extra care is needed because of the risk of bleeding at the injection site. Your doctor or nurse may give Vaqta Adult as an injection under the skin instead of into muscle (see section 3) to try to reduce the risk of deep bleeding.</p><p>&nbsp;</p><p>&nbsp;</p><p>The container of this medicinal product contains latex rubber. May cause severe allergic reactions.</p><p>&nbsp;</p><p>As with other vaccines, Vaqta Adult may not completely protect all persons who are vaccinated.</p><p>&nbsp;</p><p>Please tell your doctor if you have a history of jaundice or have lived in an area where hepatitis A is common. Your doctor will determine whether you should be tested for hepatitis A antibodies prior to vaccination.</p><p>&nbsp;</p><p>Other medicines and VAQTA Adult</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines (or other vaccines).</p><p>&nbsp;</p><p>This vaccine can be given at the same time as any of the following provided that they are given in different parts of the body (for example another arm) and are not mixed in the same syringe.</p><p>&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Vi polysaccharide typhoid vaccine,</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Yellow fever vaccine,</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Immunoglobulins (antibodies obtained from blood donors)</p><p>&nbsp;</p><p>Studies with a paediatric formulation have shown that the vaccine may be given at the same time as measles, mumps, rubella, varicella, pneumococcal 7-valent conjugate, inactivated polio, diphtheria toxoid, tetanus toxoid, acellular pertussis or <em>Haemophilus influenzae </em>type b vaccines.</p><p>&nbsp;</p><p>Pregnancy, breast-feeding and fertility</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice whether you should receive the vaccine.</p><p>&nbsp;</p><p>Driving or using machines</p><p>There are no data to suggest that Vaqta Adult affects the ability to drive or operate machinery.</p><p>&nbsp;</p><p>Vaqta Adult contains less than 1 mmol sodium (3.55 mg) per dose i.e. essentially &lsquo;sodium-free&rsquo;.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The vaccine will be injected by a doctor or nurse who has been trained in the use of vaccines and who is equipped to deal with any rare severe allergic reaction to the injection.</p><p>&nbsp;</p><p>Short term protection against hepatitis A is achieved within 2 to 4 weeks after receiving this vaccination. This may take a little longer if the injection is given under the skin, rather than into the muscle.</p><p>&nbsp;</p><p>Long-term protection against hepatitis A requires a second dose (booster injection) of an inactivated hepatitis A vaccine. This is usually given between 6 and 18 months after the first dose. This booster will protect you against hepatitis A for at least 6 years. It is predicted that hepatitis A antibodies will remain at least 25 years after vaccination.</p><p>&nbsp;</p><p>If necessary, Vaqta Adult can be given as a booster injection 6 to 12 months after you received a first dose of another inactivated hepatitis A vaccine.</p><p>&nbsp;</p><p>Method of administration</p><p>The doctor or nurse will shake the syringe immediately before use and check that the liquid is white and cloudy and that there are no large particles.</p><p>&nbsp;</p><p>The vaccine is given as an injection into a muscle in the upper outer part of the arm. Your doctor or nurse will avoid giving you the injection either into the skin or into a blood vessel. People who are at risk of bleeding a lot after an injection (see section 2) may sometimes be given Vaqta Adult as an injection under the skin but not into muscle to try to reduce the risk of bleeding.</p><p>&nbsp;</p><p>Use in children and adolescents</p><p>Vaqta Adult is not recommended for individuals less than 18 years of age.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines and vaccines, this vaccine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>As with all vaccines, allergic reactions, in rare cases leading to shock, may occur. These reactions may include:</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->hives</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->difficulty in breathing</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->swelling of the face, tongue and throat</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->dizziness</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->collapse.</p><p>When these signs or symptoms occur they usually develop very quickly after the injection is given and while you are still in the clinic or doctor&rsquo;s surgery. <strong>If any of these symptoms occurs after leaving the place where you received the injection, contact a doctor IMMEDIATELY.</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:.4in; vertical-align:top; width:94.45pt"><p><strong>Frequency</strong><strong> </strong><strong>of</strong><strong> </strong><strong>side</strong><strong> </strong><strong>effects</strong></p></td><td style="border-color:black; height:.4in; vertical-align:top; width:330.6pt"><p><strong>Side</strong><strong> </strong><strong>effects</strong></p></td></tr><tr><td style="border-color:black; height:69.5pt; vertical-align:top; width:94.45pt"><p>Very common: may affect more than 1 in 10 people</p></td><td style="height:69.5pt; vertical-align:top; width:330.6pt"><p>injection-site tenderness, pain, warmth, swelling, redness</p></td></tr><tr><td style="border-color:black; height:84.6pt; vertical-align:top; width:94.45pt"><p>Common: may affect up to 1 in 10 people</p></td><td style="height:84.6pt; vertical-align:top; width:330.6pt"><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->headache</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->arm pain (in the injected arm)</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->weakness/tiredness, fever (38.3&deg;C or over), bleeding under the skin at the injection site (ecchymosis), pain and soreness</p></td></tr><tr><td style="border-color:black; height:70.7pt; vertical-align:top; width:94.45pt"><p>Uncommon: may affect up to 1 in 100 people</p></td><td style="height:70.7pt; vertical-align:top; width:330.6pt"><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sore throat, upper respiratory infections</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->swelling of the lymph nodes</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->dizziness, abnormal skin sensations such as tingling</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ear ache</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->hot flushes</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>&nbsp;</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:194.9pt; vertical-align:top; width:94.45pt"><p>&nbsp;</p></td><td style="border-color:black; height:194.9pt; vertical-align:top; width:330.6pt"><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->runny or blocked nose and airways, cough</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->feeling sick (nausea), diarrhoea, excessive gas in the stomach and intestines, vomiting</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->hives, itching, redness</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->muscle pain, stiffness, shoulder pain, musculoskeletal pain (pain that affects the muscles, ligaments and tendons, along with the bones) back pain, joint pain, leg pain, neck pain, muscle weakness</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->itching at the injection-site, stiffness/tightness, pain, bruising at the injection-site, chills, stomach ache, feeling generally unwell, hardness (induration) and numbness at the injection-site, cold sensation, flu-like illness</p></td></tr><tr><td style="border-color:black; height:224.15pt; vertical-align:top; width:94.45pt"><p>Rare: may affect up to 1 in 1,000 people</p></td><td style="height:224.15pt; vertical-align:top; width:330.6pt"><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->bronchitis, inflammation of the stomach and intestines (gastroenteritis)</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->loss of appetite</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->lacking energy, trouble sleeping</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sleepiness, migraine, tremor</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->itching eyes, sensitivity to light, increased flow of tears</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->vertigo</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->swelling of the throat, problems with the sinuses</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->dryness of the mouth, mouth ulcers</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->night sweats, rash, skin disorders</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->muscle cramp, elbow pain, hip pain, jaw pain, spasm</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->problems with periods</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->injection-site burning, lump (&le;2.5 centimetres), muscle twitching, rash, swelling of the stomach, chest pain, pain in the side; irritability</p></td></tr><tr><td style="border-color:black; height:83.3pt; vertical-align:top; width:94.45pt"><p>Not known: frequency cannot be estimated from the available data</p></td><td style="height:83.3pt; vertical-align:top; width:330.6pt"><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Guillain-Barr&eacute; syndrome (muscle weakness, abnormal sensations, tingling in the arms, legs and upper body)</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->thrombocytopenia (reduction in blood platelets which increases risks of bleeding and bruising)</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p>Reporting of side effects</p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via (the National Pharmacovigilance and Drug Safety Centre (NPC). SFDA).</p><p>By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this vaccine out of the sight and reach of children.</p><p>&nbsp;</p><p>The vaccine should not be used after the expiry date (Exp) which is stated on the carton and vial label.</p><p>&nbsp;</p><p>The vaccine must be stored in a refrigerator between 2&deg;C and 8&deg;C (making sure that it does not freeze) so that the vaccine keeps its effectiveness.</p><p>&nbsp;</p><p>Do not use this vaccine if you notice that it has an unusual appearance (see section 6) or contains particulate matter.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>The active ingredient is: Inactivated hepatitis A virus (produced on MRC-5 human diploid cells, adsorbed on amorphous aluminium hydroxyphosphate sulfate).</p><p>&nbsp;</p><p>One dose (1 mL) contains 50U hepatitis A virus (inactivated) adsorbed on aluminium hydroxyphosphate sulphate (0.45 milligram as aluminium).</p><p>The other ingredients are:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sodium borate decahydrate (0.070 mg/dose)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sodium chloride (9 mg/dose)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->water for injections ( q.s.).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
A pre-filled syringe or vial containing 1 millilitre (one dose) of the vaccine. The vaccine is available in single packs of the vial or pre-filled syringe with or without a needle.

Not all presentations may be marketed.
After thorough agitation Vaqta Adult is an opaque white suspension.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder</p><p>&nbsp;</p><p>Merck Sharp &amp; Dohme B.V.</p><p>Waarderweg 39, 2031 BN Haarlem, The Netherlands.</p><p>&nbsp;</p><p>Manufacturer</p><p>Merck Sharp &amp; Dohme LLC.</p><p>Sumneytown Pike, P.O. Box 4, West Point, PA, USA</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in December 2020.
To report side effects:
•	Saudi Arabia: 
The National Pharmacovigilance Centre (NPC):
SFDA Call Center: 19999
E-mail: npc.drug@sfda.gov.sa
Website: https://ade.sfda.gov.sa

•	Other GCC States: 
Please contact the relevant competent authority.

This is a Medicament
•	Medicament  is  a  product  which  affects  your  health  and  its  consumption  contrary  to Instructions are dangerous for you.
•	Follow strictly the doctor’s prescription, the method of use and the instructions of the pharmacist who sold the medicament.
•	The doctor and the pharmacist are the experts in medicines, their benefits and risks.
•	Do not by yourself interrupt the period of treatment prescribed for you.
•	Do not repeat the same prescription without consulting your doctor.
•	Keep all medicaments out of reach of children.

Council of Arab Health Ministers  
 Union of Arab Pharmacists

This patient information leaflet is approved by the Saudi Food & Drug Authority. 


The following information is intended for healthcare professionals only: Incompatibilities
In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.

Instructions for use and handling

The vaccine should be used as supplied.

The vaccine should be inspected visually prior to administration for any foreign particulate matter and/or abnormal physical appearance. Discard the product if particulates are present or if it appears discoloured. The syringe should be well shaken until a slightly opaque white suspension is obtained.

Thorough agitation is necessary to maintain suspension of the vaccine. For syringe without attached needle, hold the syringe barrel and attach the needle by twisting in clockwise direction until the needle fits securely on the syringe and give the vaccine immediately.


            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>ينتمي فاكتا البالغين إلى مجموعة كاملة من الأدوية تسمى اللقاحات. وتستخدم اللقاحات في الوقاية من الأمراض المُعدية. فهي تعمل عن طريق حث الجسم على إنتاج حمايته الخاصة ضد المرض المستهدف.</p><p>يساعد هذا اللقاح على الوقاية من عدوى التهاب الكبد الوبائي أ A.</p><p>التهاب الكبد الوبائي أ &nbsp;Aهو فيروس يهاجم الكبد، ويمكن أن ينتقل من خلال الطعام أو الشراب المُلوّث بالفيروس. وتشمل أعراض التهاب الكبد أ &nbsp;A اصفرار الجلد والعينين (اليرقان) والشعور العام بالتوعك.</p><p>عندما يُحقن هذا اللقاح، تقوم الدفاعات الطبيعية في الجسم بإنتاج حماية (الأجسام المضادة) ضد عدوى التهاب الكبد الوبائي أ A. ولكن ، يستغرق الجسم مدة 2-4 أسابيع عادة قبل أن تحصل على الحماية بعد &nbsp;تلقي المطعوم.</p><p>لن يحمي هذا اللقاح ضد الفيروسات الأخرى التي تصيب الكبد (مثل التهاب الكبد الوبائي بي B، التهاب الكبد الوبائي سي C أو التهاب الكبد الوبائي إي E). هذا اللقاح يحمي من التهاب الكبد الوبائي أ A ولكن لا يمكن أن يسبب عدوى التهاب الكبد الوبائي أ A.</p><p>قد لا يعمل المطعوم بشكل صحيح إذا كان الشخص المُراد تطعيمه مصابًا بالفعل بفيروس التهاب الكبد الوبائي أ A.</p><p>فاكتا البالغين مُعد للبالغين بدءًا من عمر 18 سنة وما فوق. هذا اللقاح غير مناسب لأي شخص دون سن 18 سنة من العمر. &nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تستخدم فاكتا </strong>البالغين <strong>إذا:</strong></p><p>&bull; كان لديك حساسية نحو المادة الفعالة أو نحو أيّ من المكونات الأخرى في فاكتا الكِبار (المُدرجة في الفقرة رقم 6) أو نحو النيومايسين أو الفورمالدهيد (انظر فقرة &quot;المحاذير والاحتياطات&quot;).<br />&bull; كنت مريضًا ولديك حمّى عالية. يجب تأجيل التطعيم حتى تستعيد عافيتك.</p><p>&nbsp;</p><p><strong>المحاذير والاحتياطات</strong><br />تحدث مع طبيبك أو الصيدلي أو الممرض قبل إعطاء فاكتا البالغين :<br />&bull; إذا سبق وتعرّضت لرد فعل تحسسي مع جرعة سابقة من فاكتا الكِبار. قد يحتوي هذا اللقاح على آثار لمضاد حيوي يُسمى النيومايسين ومادة تسمى الفورمالديهايد ، وكلاهما يستخدم أثناء إنتاج اللقاح وقد يتواجدان في اللقاح بكميات ضئيلة.<br />&bull; إذا كان لديك جهاز مناعي ضعيف أو منخفض، وذلك بسبب:<br />&nbsp;&nbsp;&nbsp;- الكورتيكوستيرويدات، الأدوية السامة للخلايا &quot;العلاج الكيميائي&quot; &nbsp;أو العلاج الإشعاعي. قد ينتظر طبيبك أو ممرضتك حتى انتهاء العلاج.<br />&nbsp;&nbsp; - عدوى فيروس نقص المناعة البشري (إش أي في HIV) أو أي مرض يؤثر على الجهاز المناعي. قد لا يحمي اللقاح هذه الفئة من المرضى كما يحمي الأشخاص الذين يتمتعون بجهاز مناعي سليم.<br />&bull; إذا كان لديك أي مشاكل في الدم تُؤدي إلى حدوث الكدمات أو النزيف بسهولة ولفترة طويلة بعد تعرّضك لجروح طفيفة. هنا قد ینصح طبیبك أو ممرضك في إعطائك فاكتا البالغين ولكن مع أخذ المزيد من العناية بسبب خطر حدوث النزیف في موضع الحقن. قد يعطيك طبيبك أو ممرضك فاكتا البالغين كحقنة تحت الجلد بدلًا من حقنة في العضل (انظر الفقرة رقم 3) في محاولة للحد من خطر حدوث نزيف عميق.</p><p>تحتوي عبوة هذا المنتج الطبي على مطاط اللاتكس والذي قد يسبب حساسية شديدة.</p><p>كما هو الحال مع اللقاحات الأخرى، قد لا يؤدي فاكتا البالغين إلى الحماية التامة لدى جميع من يتلقونه. &nbsp;</p><p>یرجی إخبار طبیبك إذا کان لدیك تاریخ من الإصابة باليرقان أو سبق لك العيش في منطقة یعتبر &nbsp;التهاب الكبد الوبائي أ A شائعًا. سوف یحدد طبیبك إذا کان ینبغي فحص الأجسام المضادة لالتهاب الكبد الوبائي أ A لديك قبل التطعیم.</p><p><br /><strong>الأدوية أخرى و فاكتا البالغين </strong><br />أخبر طبيبك أو الصيدلي إذا كنت تتناول ، قد تناولت مؤخرًا أو قد تتناول أي أدوية أخرى (أو لقاحات الأخرى).</p><p>يمكن إعطاء هذا اللقاح في نفس الوقت الذي يتم فيه إعطاء أي من اللقاحات التالية بشرط إعطاءها في أجزاء مختلفة من الجسم (على سبيل المثال الذراع الاخرى) ولا يتم خلطها في نفس الحقنة.</p><p>&nbsp; &bull; لقاح التيفوئيد متعدد السكّريات،<br />&nbsp; &bull; لقاح الحمى الصفراء،<br />&nbsp; &bull; الغلوبولين المناعي (الأجسام المضادة التي تم الحصول عليها من المتبرعين بالدم)</p><p>وقد بيّنت الدراسات التي أُجريت باستخدام تركيبة اللقاح الخاصة بالأطفال أنه يمكن إعطاء هذا اللقاح في نفس الوقت مع لقاحات الحصبة ، والنكاف ، والحصبة الألمانية ، والحماق (جدري الماء)، والمكورات الرئوية السباعي التكافؤ المٌتحد ، وشلل الأطفال (المعطل) ، وذوفان الخناق &quot;توكسويد الدفتيريا&quot; ، وذوفان الكزاز ، والسعال الديكي اللاخلوي ، ولقاحات المستدمية النزلية ب &quot;هيموفيلاس انفلونزا ب&quot;.<br /><br /><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong><br />إذا كنت حاملًا أو مرضعًا ، تعتقدين أنك قد تكونين حاملًا أو تُخططين لإنجاب طفل، استشيري طبيبك أو الصيدلي لتتحققي إذا كان ينبغي أن تتلقين اللقاح.</p><p><strong>&nbsp;</strong></p><p><strong>القيادة واستخدام الآلات</strong></p><p>لا توجد بيانات تشير إلى أن فاكتا البالغين يؤثر على القدرة على القيادة أو تشغيل الآلات.</p><p><strong>فاكتا </strong>البالغين <strong>يحتوي على أقل من 1 مليمول من الصوديوم (3.55 مجم) في كل جرعة، أي أساسا &quot;خالية من الصوديوم&quot;.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سيتم حقن اللقاح من قبل طبيب أو ممرض تم تدريبه على استخدام اللقاحات وعلى التعامل مع أي رد فعل تحسسي شديد نادر قد ينجم عن الحقن.</p><p>وتتحقق الحماية على المدى القصير ضد التهاب الكبد الوبائي أ A &nbsp;في غضون 2-4 أسابيع بعد التطعيم بهذا اللقاح. قد تستغرق هذه العملية وقتًا أطول قليلًا إذا تم الحقن تحت الجلد ، وليس في العضلات .</p><p>وتتطلب الحماية على المدى الطويل ضد التهاب الكبد الوبائي أ A حقن جرعة ثانية (معززة) من لقاح التهاب الكبد الوبائي أ A &nbsp;غير الفعال. وعادة تُعطى الجرعة الثانية بين 6 و 18 شهرا بعد الجرعة الأولى. ستؤمن لك الجرعة الثانية المُعزّزة الحماية ضد التهاب الكبد الوبائي أ A لمدة 6 سنوات على الأقل. ومن المتوقع أن تبقى الأجسام المضادة لالتهاب الكبد الوبائي أ A في الجسم على الأقل 25 عامًا بعد التطعيم.</p><p>إذا لزم الأمر، يمكن إعطاء فاكتا البالغين كحقنة معززة بعد تلقي الجرعة الأولى من لقاح آخر لالتهاب الكبد الوبائي أ A غير الفعال بمدة 6-12 شهرا.</p><p><strong>طريقة الإعطاء </strong></p><p>سوف يرجّ الطبيب أو الممرض الحقنة مباشرة قبل الاستخدام ويتحقق من أن السائل أبيض وغائم وأنه لا يحتوي على جزيئات كبيرة.</p><p>يعطى اللقاح كحقنة في العضل في الجزء الخارجي العلوي من الذراع. سيتجنّب طبيبك أو ممرضك إعطاءك الحقنة في الجلد أو في وعاء دموي. قد يتم إعطاء اللقاح الأفراد ممن هم عرضة لخطر حدوث نزيف كثير بعد الحقن (انظر الفقرة رقم 2) في بعض الأحيان بإعطاء فاكتا البالغين كحقنة تحت الجلد ولكن ليس في العضل في محاولة للحد من خطر النزيف.</p><p>&nbsp;</p><p><strong>الاستخدام في الأطفال والمراهقين </strong></p><p>لا ينصح باعطاء فاكتا للأفراد أقل من 18 عامًا.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال مع سائر الأدوية واللقاحات ، يمكن أن يسبب هذا اللقاح أعراضًا جانبية ، وإن كانت لا تحدث لدى جميع من يتلقوه.</p><p>كما هو الحال مع جميع اللقاحات، قد تحدث ردود فعل تحسسية، والتي قد تؤدي في حالات نادرة إلى الصدمة. وقد تشمل هذه التفاعلات ما يلي:<br />- الشرى<br />- صعوبة في التنفس<br />- تورم في الوجه واللسان والحلق<br />- الدوخة<br />- الانهيار<br />عندما تحدث هذه العلامات أو الأعراض فإنها عادة تتطور بسرعة كبيرة بعد إعطاء الحقنة وغالبًا أثناء وجودك في عيادة التطعيم أو الجراحة. <strong>إذا حدث أيّ من هذه الأعراض بعد مغادرة المكان الذي تلقيت فيه الحقنة، اتصل بالطبيب فورا.</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top; width:162.95pt"><p><strong>تكرار حدوث الأعراض الجانبية</strong></p></td><td style="vertical-align:top; width:304.55pt"><p><strong>الأعراض الجانبية</strong></p></td></tr><tr><td style="vertical-align:top; width:162.95pt"><p>شائعة جدا: قد تؤثر على أكثر من 1 من بين 10 أشخاص</p></td><td style="vertical-align:top; width:304.55pt"><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم في موضع الحقن ، دفء ، تورّم ، واحمرار في موضع الحقن.</p></td></tr><tr><td style="vertical-align:top; width:162.95pt"><p>شائعة: قد تؤثر على ما يصل إلى 1 من بين 10 أشخاص</p></td><td style="vertical-align:top; width:304.55pt"><p>- صداع</p><p>- ألم في الذراع (التي تم الحقن فيها)<br />- ضعف/تعب، حُمّى (تصل إلى 38.3 درجة مئوية أو أكثر)، نزيف تحت الجلد في موضع الحقن (كدمات) ، ألم واحتقان</p></td></tr><tr><td style="vertical-align:top; width:162.95pt"><p>غير شائعة: قد تؤثر على ما يصل إلى 1 من بين 100 شخص</p></td><td style="vertical-align:top; width:304.55pt"><p>- التهاب الحلق ، عدوى الجهاز التنفسي العلوي</p><p>- تورّم الغدد اللمفاوية<br />- الدوخة، وأحاسيس غير طبيعية في الجلد مثل وخز</p><p>- آلام الأذن</p><p>- هبات الحرارة</p><p>- سيلان أو انسداد الأنف والممرات الهوائية ، والسعال</p><p>- الشعور بالمرض (الغثيان) ، والإسهال ، والغاز المفرط في المعدة<br />&nbsp;&nbsp; والأمعاء ، والتقيؤ</p><p>- الشرى ، والحكة ، واحمرار</p><p>- آلام في العضلات، تيبّس، آلام في الكتف، ألم عضلي هيكلي<br />&nbsp;&nbsp; (ألم يؤثر على العضلات والأربطة والأوتار، إلى جانب العظام)<br />&nbsp;&nbsp; آلام الظهر ، آلام المفاصل، ألم في الساق، آلام الرقبة،<br />&nbsp;&nbsp; ضعف العضلات</p><p>- الحكة في موضع الحقن، وتيبّس/ضيق، ألم، كدمات في موضع الحقن، قشعريرة، آلام في المعدة، والشعور العام بالتوعك، الصلابة (جساوة أو قساوة) وخدر في موضع الحقن، الإحساس ببرودة، مرض يشبه الانفلونزا</p></td></tr><tr><td style="vertical-align:top; width:162.95pt"><p>نادرة: قد تؤثر على ما يصل إلى 1 من بين 1000 شخص</p></td><td style="vertical-align:top; width:304.55pt"><p>- التهاب القصبات الهوائية ، التهاب المعدة والأمعاء</p><p>- فقدان الشهية</p><p>- الافتقار إلى الطاقة ، مشاكل في النوم</p><p>- النعاس، الصداع النصفي، الارتعاش</p><p>- حكة في العيون، والحساسية للضوء، وزيادة تدفق الدموع</p><p>- الدُّوَار</p><p>- تورم في الحلق، ومشاكل مع الجيوب الأنفية</p><p>- جفاف الفم، تقرحات الفم</p><p>- تعرق ليلي، طفح جلدي، اضطرابات جلدية</p><p>- تقلصات العضلات، آلام الكوع، ألم الورك، آلام الفك، تشنج</p><p>- مشاكل في الدورة الشهرية</p><p>- نتوء في موضع الحقن، تورّم (&le;2،5 سم)، وارتعاش العضلات،&nbsp;<br />&nbsp;&nbsp; والطفح الجلدي، وتورم في المعدة، وآلام في الصدر، وآلام في<br />&nbsp;&nbsp; الجانب. الهيجان</p></td></tr><tr><td style="vertical-align:top; width:162.95pt"><p>غير معروف: لا يمكن تقدير تكرار الحدوث من البيانات المتاحة</p></td><td style="vertical-align:top; width:304.55pt"><p>- متلازمة غيلان باريه (ضعف العضلات، والأحاسيس غير<br />&nbsp;&nbsp; الطبيعية، وخز في الذراعين والساقين والجزء العلوي من الجسم)</p><p>- نقص الصفيحات (انخفاض عدد الصفائح الدموية مما يزيد من<br />&nbsp;&nbsp; مخاطر النزيف والكدمات)</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>الإبلاغ عن الأعراض الجانبية</strong><br />إذا تعرّضت لأي أعراض جانبية، تحدث مع طبيبك أو الصيدلي أو الممرض. ويشمل ذلك أي أعراض جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضا الإبلاغ عن الأعراض الجانبية مباشرة عن طريق &quot;المركز الوطني للتيقظ والسلامة الدوائية&quot; ، التابع للهيئة العامة للغذاء والدواء ، المملكة العربية السعودية. وبالإبلاغ عن الأعراض الجانبية يمكنك المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يُحفظ هذا اللقاح بعيدا عن مرأى ومتناول الأطفال.</p><p>یجب عدم استخدام اللقاح بعد تاریخ &nbsp;انتهاء الصلاحیة (EXP) الذي &nbsp;يظهر علی العلبة من الخارج وملصق &nbsp;الفيال.</p><p>يجب أن يتم تخزين اللقاح في الثلاجة بين 2 - 8 درجة مئوية (للتأكد من أنه لا يتجمّد) بحيث يحتفظ اللقاح بفعاليته.</p><p>لا تستخدم هذا اللقاح إذا لاحظت أن لديه مظهر غير عادي (انظر الفقرة رقم 6) أو يحتوي على الجسيمات.</p><p>لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. وستساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>العنصر النشط هو: فيروس التهاب الكبد الوبائي أ غير الفعال(الذي يتم إنتاجه على الخلايا البشرية المُضاعفة إم أر سي 5 ، مُمتزّ على كبريتات هيدروكسي فوسفات الألمنيوم).</p><p>&nbsp;</p><p>تحتوي كل جرعة واحدة (1 ملل) على 50 وحدة من فيروس التهاب الكبد الوبائي&nbsp; أ A ( غير الفعال) الممتزّ على كبريتات هيدروكسي فوسفات الألمنيوم (0.45 ملليجرام من الألومنيوم).</p><p>المكونات الأخرى هي:</p><p>&bull; بورات الصوديوم ديكاهيدرات (070&sbquo; 0 ملغم/جرعة)<br />&bull; كلوريد الصوديوم (9 ملغم/جرعة)<br />&bull; الماء المُخصّص للحقن (الكمية الكافية)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ما هو شكل فاكتا البالغين ومحتويات العبوة يتوفر لقاح فاكتا على شكل حقن مُسبقة التعبئة أو فيال تحتوي على 1 ملليلتر (جرعة واحدة) من اللقاح. علبة اللقاح تحتوي عبوة واحدة من الفيال أو حقن مُسبقة التعبئة مع أو بدون إبرة. قد لا تُسوق جميع أنواع العبوات. يظهر لقاح فاكتا بعد الرجّ الجيد على شكل مُعلّق أبيض معتم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>الشركة المالكة لحقوق التسويق :</strong><br />ميرك شارب و دوهم بي في ،<br />وارديرويج 39، 2031 بي ان هارلم<br />هولندا</p><p><strong>&nbsp;</strong></p><p><strong>الشركة المُصَنّعة:</strong><br />شركة ميرك، شارب ودوهم ذ م م ،<br />سومنيتون بايك، صندوق بريد 4، ويست بوينت، بي إيه ، الولايات المتحدة الأمريكية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
تمت الموافقة على هذه النشرة بتاريخ { ديسمبر 2020}
للإبلاغ عن الأعراض الجانبية:
•	المملكة العربية السعودية:
المركز الوطني للتيقظ والسلامة الدوائية
للاتصال باالهيئة العامة للغذاء والدواء: 1999
البريد الالكتروني: npc.drug@sfda.gov.sa
الموقع الالكتروني: https://ade.sfda.gov.sa
•	دول الخليج الأخرى
الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.

(إنّ هذا الدواء)
- الدواء مستحضر يؤثر على صحتك واستهلاكه خلافًا للتعليمات يعرضك للخطر
- اتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها وتعليمات الصيدلاني الذي صرفها لك
- إن الطبيب والصيدلاني هما الخبيران بالدواء وبنفعه وضرره
- لا تقطع مدة العلاج المحددة لك من تلقاء نفسك
- لا تكرر صرف الدواء بدون استشارة الطبيب
- لا تترك الأدوية في متناول أيدي الأطفال
مجلس وزراء الصحة العرب
و اتحاد الصيادلة العرب
تمت الموافقة على نشرة المعلومات الخاصة بالمريض من قبل الهيئة العامة للغذاء والدواء السعودية
المعلومات التالية مُوجهة لأخصائيي الرعاية الصحية فقط:
عدم التوافق
يجب عدم خلط هذا المنتج الطبي مع المنتجات الطبية الأخرى لأنّه لا تتوفر دراسات عن التوافق مع المنتجات الطبيّة الأخرى.
تعليمات الاستخدام 
يجب استخدام اللقاح كما هو بدون أي تغيير.
وينبغي فحص اللقاح بصريًّا قبل إعطاء اللقاح تحسّبًا لوجود أي جسيمات غريبة و/أو مظهر غير طبيعي. تخلّص من المنتج إذا لاحظت وجود جسيمات أو تغير في اللون. يجب رجّ المِحقنة بشكل جيد حتى يتم الحصول على مُعلّق أبيض غميم قليلا.
الرجّ الشامل ضروري للحفاظ على اللقاح بشكل مُعلّق. ولوصل الإبرة بالمِحقنة التي تتوفر بدون إبرة متصلة بها، امسك بالمحقنة من الجزء الاسطواني ثم صِل الإبرة بها وقم بلفّ الإبرة في اتجاه عقارب الساعة حتى تثبت في مكانها على المِحقنة بشكل آمن وقم بإعطاء اللقاح على الفور.

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                VAQTA® 50U/1.0 ml vial , suspension for injection
Hepatitis A vaccine, inactivated, adsorbed. For adults.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One dose (1mL) contains:
Hepatitis A virus (strain CR 326F) (inactivated) 1, 2  …………………50 U3
1 Produced on human diploid (MRC–5) fibroblast cells.
2  Adsorbed on amorphous aluminium hydroxyphosphate sulphate (0.45 mg Al3+).
3 Units measured according to the in-house method of the manufacturer-Merck Sharp & Dohme LLC.

This vaccine may contain traces of neomycin and formaldehyde, which are used during the manufacturing process. See sections 4.3 and 4.4.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suspension for injection in a vial.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>VAQTA Adult is indicated for active pre-exposure prophylaxis against disease caused by hepatitis A virus. VAQTA Adult is recommended for healthy adults 18 years of age and older who are at risk of contracting or spreading infection or who are at risk of life-threatening disease if infected (e.g., those with Human Immunodeficiency Virus [HIV] or hepatitis C with diagnosed liver disease).</p><p>&nbsp;</p><p>The use of VAQTA Adult should be based on official recommendations.</p><p>&nbsp;</p><p>For optimal antibody response, primary immunisation should be given at least 2, preferably 4, weeks prior to expected exposure to hepatitis A virus.</p><p>&nbsp;</p><p>VAQTA Adult will not prevent hepatitis caused by infectious agents other than hepatitis A virus.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><!--[if !supportLists]-->1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Posology</p><p>The vaccination series consists of one primary dose and one booster dose given according to the following schedule:</p><p>&nbsp;</p><p><em>Primary</em><em> </em><em>dose:</em></p><p>Adults 18 years of age and older should receive a single 1.0 mL (50U) dose of vaccine at an elected date.</p><p>&nbsp;</p><p><em>Booster dose:</em></p><p>Adults 18 years of age and older who received a primary dose should receive a booster dose of 1.0 mL (50U) 6 to 18 months after the first dose.</p><p>&nbsp;</p><p>Hepatitis A virus (HAV) antibodies persist for at least 6 years after the second dose (i.e. booster). Based on mathematic modeling duration of antibody persistence is predicted for at least 25 years (see section 5.1).</p><p>&nbsp;</p><p><em>Interchangeability</em><em> </em><em>of the booster dose</em></p><p>A booster dose of VAQTA may be given at 6 to 12 months following the initial dose of other inactivated hepatitis A vaccines. (See section 5.1.)</p><p>&nbsp;</p><p><em>Adults</em><em> </em><em>with HIV:</em></p><p>HIV-infected adults should receive a single dose of 1.0mL (50U) of VAQTA Adult at an elected date followed by a booster dose of 1.0mL (50U) 6 months later.</p><p>&nbsp;</p><p><em>Paediatric</em><em> </em><em>population</em></p><p>There is a paediatric formulation available for children and adolescents. For details please refer to the Summary of Product Characteristics for VAQTA Paediatric.</p><p>&nbsp;</p><p><em>Method</em><em> </em><em>of Administration</em></p><p>VAQTA Adult should be injected INTRAMUSCULARLY in the deltoid region. The vaccine should not be administered intradermally since administration by this route may result in a less than optimal response.</p><p>&nbsp;</p><p>For individuals with bleeding disorders who are at risk of haemorrhage following intramuscular injection (e.g. haemophiliacs), this vaccine may be administered subcutaneously (see section 5.1).</p><p>&nbsp;</p><p><em>Precautions </em><em>to be taken before handling or administering the medicinal product </em>For instructions on preparation of the medicinal product before administration, see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                History of hypersensitivity to the active substances, to any of the excipients listed in section 6.1, to neomycin or to formaldehyde (which may be present as trace residues, see sections 2 and 4.4).

Vaccination should be delayed in subjects with current severe febrile infections.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong></p><p><u>Traceability</u></p><p>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p><p>&nbsp;</p><p>Individuals who develop symptoms suggestive of hypersensitivity after an injection of VAQTA Adult should not receive further injections of the vaccine. This vaccine may contain traces of neomycin and formaldehyde which are used during the manufacturing process (see sections 2 and 4.3).</p><p>&nbsp;</p><p>VAQTA Adult must not be administered into a blood vessel.</p><p><strong>&nbsp;</strong></p><p>Use caution when vaccinating latex-sensitive individuals since the syringe plunger stopper and tip cap contain dry natural latex rubber that may cause allergic reactions.</p><p>&nbsp;</p><p>Qualitative testing for antibodies to hepatitis A prior to immunisation should be considered based on the probability of previous hepatitis A virus infection in patients who grew up in areas of high endemicity, and/or with a history of jaundice.</p><p>&nbsp;</p><p>VAQTA Adult does not cause immediate protection against hepatitis A, and there may be a period of 2 to 4 weeks before antibody becomes detectable.</p><p>&nbsp;</p><p>VAQTA Adult will not prevent hepatitis caused by infectious agents other than hepatitis A virus. Because of the long incubation period (approximately 20 to 50 days) for hepatitis A, it is possible for unrecognised hepatitis A infection to be present at the time the vaccine is given. The vaccine may not prevent hepatitis A in such individuals.</p><p>&nbsp;</p><p>As with any vaccine, adequate treatment provisions, including epinephrine (adrenaline), should be available for immediate use should an anaphylactic or anaphylactoid reaction occur.</p><p>&nbsp;</p><p>VAQTA Adult may be administered subcutaneously when clinically appropriate (e.g. for people with bleeding disorders who are at risk of haemorrhage), although the kinetics of seroconversion are slower for the first subcutaneous dose of VAQTA Adult compared with historical data for intramuscular administration.</p><p>&nbsp;</p><p>As with any vaccine, vaccination with VAQTA Adult may not result in a protective response in all susceptible vaccinees.</p><p>&nbsp;</p><p>Excipient(s) with known effect:</p><p>This medicinal product contains less than 1 mmol (23 mg) sodium per dose and is considered to be essentially sodium free.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If VAQTA Adult is used in individuals with malignancies or those receiving immunosuppressive therapy or who are otherwise immunocompromised, the expected immune response may not be obtained.</p><p>&nbsp;</p><p><em>Known or presumed exposure to HAV/Travel to endemic areas Use with immune globulin</em></p><p>For individuals requiring either post-exposure prophylaxis or combined immediate and longer term protection (e.g., travellers departing on short notice to endemic areas), in countries where IG is available VAQTA Adult may be administered concomitantly with IG using separate sites and syringes. Although the antibody titre obtained is likely to be lower than when the vaccine is given alone. The clinical relevance of this observation has not been established.</p><p>&nbsp;</p><p><em>Use</em><em> with other vaccines</em></p><p>VAQTA Adult may be given concomitantly at separate injection sites with yellow fever and polysaccharide typhoid vaccines (see section 5.1). Though data in subjects 18 years of age and older are not available, studies in children 12 through 23 months of age have shown that VAQTA may be administered concomitantly with measles, mumps, rubella, varicella, pneumococcal 7-valent conjugate and inactivated polio vaccines. Immunogenicity data are insufficient to support concomitant administration of VAQTA with DTaP (Diphtheria, Tetanus and acellular Pertussis) vaccine.</p><p>&nbsp;</p><p>Interaction studies other than with yellow fever and polysaccharide typhoid vaccines are not yet available; however, interactions with other vaccines are not anticipated when vaccines are administered at different injection sites.</p><p>When concurrent administration is necessary, VAQTA Adult must not be mixed with other vaccines in the same syringe, and other vaccines should be administered at different sites.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>It is not known whether VAQTA Adult can cause foetal harm when administered to a pregnant woman, or can affect reproduction capacity. VAQTA Adult is not recommended in pregnancy unless there is a high risk of hepatitis A infection, and the attending physician judges that the possible benefits of vaccination outweigh the risks to the foetus.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known whether VAQTA Adult is excreted in human milk, and the effect on breastfed infants following administration of VAQTA Adult to mothers has not been studied. Hence, VAQTA Adult should be used with caution in women who are breastfeeding.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>VAQTA Adult has not been evaluated in fertility studies.</p><p>&nbsp;</p><p>Animal reproduction studies have not been conducted with VAQTA Adult.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, VAQTA Adult is expected to have no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><!--[if !supportLists]-->1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Summary of the safety profile</p><p>In clinical trials with 1,529 healthy adults who received one or more doses of hepatitis A vaccine, subjects were followed for elevated temperature and local reactions during a 5-day period postvaccination and systemic adverse events including fever during a 14-day period postvaccination. Injection-site reactions, generally mild and transient, were the most frequently reported adverse events.</p><p>&nbsp;</p><p><em>Post-marketing</em><em> </em><em>safety study</em></p><p>In a post-marketing safety study, a total of 29,587 individuals &sup3; 18 years of age received 1 or 2 doses of VAQTA Adult. There was no serious, vaccine-related, adverse event identified. There was no nonserious, vaccine-related, adverse event resulting in outpatient visits, with the exception of diarrhoea/gastroenteritis in adults at a rate of 0.5%.</p><p>&nbsp;</p><p>Tabulated summary of adverse reactions</p><p><strong>&nbsp;</strong></p><p>The table presents adverse reactions reported as vaccine related observed in clinical trials, and in a post-authorisation safety study and adverse reactions spontaneously reported after use of the marketed vaccine.</p><p>&nbsp;</p><p>Adverse reactions are ranked under headings of frequency using the following convention:</p><p>&nbsp;</p><p><em>[Very</em><em> </em><em>Common </em><em>(</em><em>&sup3;</em><em>1/10);</em><em> </em><em>Common </em><em>(</em><em>&sup3;</em><em>1/100</em><em> </em><em>to &lt;1/10); Uncommon (</em><em>&sup3;</em><em>1/1000</em><em> </em><em>to</em></p><p><em>&lt;1/100);</em><em> &nbsp;Rare &nbsp;(</em><em>&sup3;</em><em>1/10,000</em><em> &nbsp;to &nbsp;&lt;1/1000); &nbsp;Very&nbsp; Rare &nbsp;(</em><em>&lt;</em><em>1/10,000);</em><em>&nbsp; Not&nbsp; Known (cannot be estimated from the available data)].</em></p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:.4in; vertical-align:top; width:106.2pt"><p><strong>System</strong><strong> </strong><strong>Organ</strong><strong> </strong><strong>Class</strong></p></td><td style="border-color:black; height:.4in; vertical-align:top; width:221.4pt"><p><strong>Frequency</strong></p></td><td style="border-color:black; height:.4in; vertical-align:top; width:147.0pt"><p><strong>Adverse</strong><strong> </strong><strong>reactions</strong></p></td></tr><tr><td rowspan="2" style="border-color:black; height:28.1pt; vertical-align:top; width:106.2pt"><p><em>Infections</em><em> </em><em>and infestations</em></p></td><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Pharyngitis, Upper respiratory infection</p></td></tr><tr><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Bronchitis, Infectious gastroenteritis</p></td></tr><tr><td rowspan="2" style="border-color:black; height:14.3pt; vertical-align:top; width:106.2pt"><p><em>Blood </em><em>and lymphatic system disorders</em></p></td><td style="height:14.3pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:14.3pt; vertical-align:top; width:147.0pt"><p>Lymphadenopathy</p></td></tr><tr><td style="height:27.95pt; vertical-align:top; width:221.4pt"><p>Not Known</p></td><td style="height:27.95pt; vertical-align:top; width:147.0pt"><p>Thrombocytopenia2</p></td></tr><tr><td style="border-color:black; height:42.25pt; vertical-align:top; width:106.2pt"><p><em>Metabolism</em><em> </em><em>and nutrition disorders</em></p></td><td style="height:42.25pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:42.25pt; vertical-align:top; width:147.0pt"><p>Anorexia</p></td></tr><tr><td style="border-color:black; height:28.3pt; vertical-align:top; width:106.2pt"><p><em>Psychiatric</em><em> </em><em>disorders</em></p></td><td style="height:28.3pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:28.3pt; vertical-align:top; width:147.0pt"><p>Apathy, Insomnia</p></td></tr><tr><td rowspan="4" style="border-color:black; height:14.3pt; vertical-align:top; width:106.2pt"><p><em>Nervous</em><em> </em><em>system disorders</em></p></td><td style="height:14.3pt; vertical-align:top; width:221.4pt"><p>Common</p></td><td style="height:14.3pt; vertical-align:top; width:147.0pt"><p>Headache</p></td></tr><tr><td style="height:14.3pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:14.3pt; vertical-align:top; width:147.0pt"><p>Dizziness, Paresthesia</p></td></tr><tr><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Somnolence, Migraine, Tremor</p></td></tr><tr><td style="height:14.3pt; vertical-align:top; width:221.4pt"><p>Not Known</p></td><td style="height:14.3pt; vertical-align:top; width:147.0pt"><p>Guillain-Barr&eacute; syndrome2</p></td></tr><tr><td style="border-color:black; height:28.1pt; vertical-align:top; width:106.2pt"><p><em>Eye disorders</em></p></td><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Itching eye, Photophobia, Tearing</p></td></tr><tr><td rowspan="2" style="border-color:black; height:14.3pt; vertical-align:top; width:106.2pt"><p><em>Ear and labyrinth disorders</em></p></td><td style="height:14.3pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:14.3pt; vertical-align:top; width:147.0pt"><p>Ear pain</p></td></tr><tr><td style="height:14.3pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:14.3pt; vertical-align:top; width:147.0pt"><p>Vertigo</p></td></tr><tr><td style="border-color:black; height:28.3pt; vertical-align:top; width:106.2pt"><p><em>Vascular</em><em> </em><em>disorders</em></p></td><td style="height:28.3pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:28.3pt; vertical-align:top; width:147.0pt"><p>Hot flashes</p></td></tr><tr><td rowspan="2" style="border-color:black; height:28.1pt; vertical-align:top; width:106.2pt"><p><em>Respiratory,</em><em> </em><em>thoracic </em><em>and mediastinal disorders</em></p></td><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Respiratory congestion, Nasal congestion, Cough</p></td></tr><tr><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Pharyngeal edema, Sinus disorder</p></td></tr><tr><td rowspan="2" style="border-color:black; height:41.9pt; vertical-align:top; width:106.2pt"><p><em>Gastrointestinal</em><em> </em><em>disorders</em></p></td><td style="height:41.9pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:41.9pt; vertical-align:top; width:147.0pt"><p>Nausea, Diarrhoea/ Gastroenteritis1, Flatulence, Vomiting</p></td></tr><tr><td style="height:14.3pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:14.3pt; vertical-align:top; width:147.0pt"><p>Dry mouth, Mouth ulcer</p></td></tr><tr><td rowspan="2" style="border-color:black; height:28.1pt; vertical-align:top; width:106.2pt"><p><em>Skin </em><em>and subcutaneous tissue disorders</em></p></td><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Pruritus, Urticaria, Erythema</p></td></tr><tr><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Night sweats, Rash, Skin disorder</p></td></tr><tr><td rowspan="3" style="border-color:black; height:28.1pt; vertical-align:top; width:106.2pt"><p><em>Musculoskeletal</em><em> </em><em>and connective tissue disorders</em></p></td><td style="height:28.1pt; vertical-align:top; width:221.4pt"><p>Common</p></td><td style="height:28.1pt; vertical-align:top; width:147.0pt"><p>Arm pain (in the injected arm)</p></td></tr><tr><td style="height:83.3pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:83.3pt; vertical-align:top; width:147.0pt"><p>Myalgia, Stiffness, Shoulder pain, Musculoskeletal pain, Back pain, Arthralgia, Leg pain, Neck pain, Muscle weakness</p></td></tr><tr><td style="height:41.9pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:41.9pt; vertical-align:top; width:147.0pt"><p>Muscle cramp, Elbow pain, Hip pain, Jaw pain, Spasm</p></td></tr><tr><td style="border-color:black; height:28.3pt; vertical-align:top; width:106.2pt"><p><em>Reproductive</em><em> </em><em>system and</em></p></td><td style="height:28.3pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:28.3pt; vertical-align:top; width:147.0pt"><p>Menstruation disorder</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><!--[if !mso]--></p><table cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td><!--[endif]--><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:.2in; vertical-align:top; width:106.2pt"><p><em>breast</em><em> disorders</em></p></td><td style="border-color:black; height:.2in; vertical-align:top; width:221.4pt"><p>&nbsp;</p></td><td style="border-color:black; height:.2in; vertical-align:top; width:147.0pt"><p>&nbsp;</p></td></tr><tr><td rowspan="4" style="border-color:black; height:41.9pt; vertical-align:top; width:106.2pt"><p><em>General</em><em> </em><em>disorders</em><em> and administrative site conditions</em></p></td><td style="height:41.9pt; vertical-align:top; width:221.4pt"><p>Very Common</p></td><td style="height:41.9pt; vertical-align:top; width:147.0pt"><p>Injection-site tenderness, Pain, Warmth, Swelling, Erythema</p></td></tr><tr><td style="height:56.5pt; vertical-align:top; width:221.4pt"><p>Common</p></td><td style="height:56.5pt; vertical-align:top; width:147.0pt"><p>Asthenia/Fatigue, Fever (&sup3;38.3&deg;C, Oral) Injection- site ecchymosis, Pain/Soreness</p></td></tr><tr><td style="height:110.9pt; vertical-align:top; width:221.4pt"><p>Uncommon</p></td><td style="height:110.9pt; vertical-align:top; width:147.0pt"><p>Injection-site pruritus, Stiffness/Tightness, Pain, Injection-site hematoma, Chills, Abdominal pain, Malaise, Injection-site induration and numbness, Cold sensation, Flu-like illness</p></td></tr><tr><td style="height:97.1pt; vertical-align:top; width:221.4pt"><p>Rare</p></td><td style="height:97.1pt; vertical-align:top; width:147.0pt"><p>Injection-site burning, Induration (&le;2.5 centimeters), Muscle twitching, Rash, Abdominal distention, Chest pain, Flank pain, Irritability</p></td></tr></tbody></table><p>&nbsp;</p><!--[if !mso]--></td></tr></tbody></table><p><!--[endif]-->1 Post-authorisation safety study</p><p>&nbsp;</p><p>2 Spontaneous reporting after use of marketed vaccine</p><p>&nbsp;</p><p>Description of selected adverse reactions</p><p><strong>&nbsp;</strong></p><p>As with all vaccines, allergic reactions, in rare cases leading to shock, may occur (see section 4.4).</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p>&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><u>Saudi Arabia: </u></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-20382222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><u>Other GCC States: </u></p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no data with regard to overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: viral vaccines, hepatitis A, inactivated, whole virus ATC code: J07BC02</p><p>&nbsp;</p><p>VAQTA Adult contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate.</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Hepatitis A vaccine elicits circulating neutralising antibodies to Hepatitis A virus sufficient to confer protection against the virus.</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p>Clinical studies showed seroconversion rates&nbsp; were 95% in adults&nbsp; within 4 weeks after the recommended primary dose. In a sub-set of these individuals &sup3; 60 years of age, data indicate that 88% (n=64) seroconverted by week 4 after the primary dose.</p><p>&nbsp;</p><p>In adults, seropositivity has been shown to persist up to 18 months after a single 50U dose. Persistence of immunologic memory was demonstrated with a substantial anamnestic antibody response to a booster dose of 50U given 6 to 18 months after the primary dose to adults. The data regarding the subjects more than 60 years of age are limited.</p><p>&nbsp;</p><p><em>Antibody</em><em> </em><em>persistence</em></p><p>In studies of healthy adults (18 to 41 years of age) who received an initial 50U dose of VAQTA at Day 0 and a subsequent 50U dose 6 months later, the hepatitis A antibody response to date has been shown to persist to at least 6 years. After an initial decline over 2 years, the GMTs appeared to plateau during the 2 to 6 year period.</p><p>&nbsp;</p><p>Data available from long-term studies up to 10 years on the persistence of HAV antibodies after 2 doses of VAQTA in healthy, immunocompetent subjects up to 41 years of age allows prediction that based on mathematical modelling at least 99% of subjects will remain seropositive (&ge;10 mIU anti- HAV/ml) at least 25 years after vaccination.</p><p>&nbsp;</p><p>Based on this analysis, an additional vaccination following complete primary immunisation with 2 doses appears to be unnecessary.&nbsp; However, decisions regarding additional vaccination should be based on risk-benefit for the individual.</p><p>&nbsp;</p><p><em>Interchangeability</em><em> </em><em>of the booster dose</em></p><p>A clinical study in 537 healthy adults, 18 to 83 years of age, evaluated the immune response to a booster dose of VAQTA Adult and a comparable licensed inactivated hepatitis A vaccine given at 6 or 12 months following initial dose of the comparator vaccine. When VAQTA Adult was given as a booster dose in this case it produced an equivalent immune response and was generally well tolerated. (See section 4.2.)</p><p>&nbsp;</p><p><em>Concomitant</em><em> use with immunoglobulin</em></p><p>Concurrent administration to healthy adults (18 to39 years of age) of 50 U/1.0 mL of VAQTA Adult with immunoglobulin (IG, 0.06 mL/kg) was evaluated in a clinical study. The seroconversion rate at week 24 in the vaccine alone group</p><p>&nbsp;</p><p>(97%) was higher than in the vaccine plus IG group (92% p = 0.050) but rose to 100% in both groups one month post booster.</p><p>&nbsp;</p><p><em>Concomitant</em><em> use with other vaccines</em></p><p>A controlled clinical study was conducted with 240 healthy adults, 18 to 54 years of age, who were randomised to receive either</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->VAQTA Adult, yellow fever and polysaccharide typhoid vaccines concomitantly at separate injection sites or</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->yellow fever and polysaccharide typhoid vaccines concomitantly at separate injection sites or</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->VAQTA Adult alone.</p><p>The seropositivity rate (SPR) for hepatitis A when VAQTA Adult, yellow fever and polysaccharide typhoid vaccines were administered concomitantly was generally similar to when VAQTA Adult was given alone. However the GMTs for hepatitis A were reduced when the three vaccines were administered concomitantly. Clinically, this reduction in GMTs may be less relevant compared to the benefits of concomitant administration. The antibody response rates for yellow fever&nbsp; and typhoid were equivalent when yellow fever&nbsp; and polysaccharide typhoid vaccines were administered concomitantly with and without VAQTA Adult. The concomitant administration of these three vaccines at separate injection sites was generally well tolerated. The addition of VAQTA Adult to the standard practice of administering yellow fever and typhoid vaccines does not increase the rates of injection site and systemic adverse reactions. (See section 4.2.)</p><p>&nbsp;</p><p><em>Subcutaneous administration</em></p><p>In a clinical study with 114 healthy seronegative adults who received subcutaneous administration of VAQTA Adult (50U), at 4 weeks following the first dose, the SPR was 78%, and the GMT was 21 mIU/mL. At 24 weeks following the first dose and just prior to the second subcutaneous injection, the SPR was 95%, and the GMT was 153 mIU/mL. At 4 weeks following the second subcutaneous injection, the SPR was 100%, and the GMT was 1,564 mIU/mL; the GMT was 2,287 mlU/mL in subjects less than 30 years of age compared with a GMT of 1,122 mlU/mL in subjects 30 years of age and older. The kinetics of seropositivity were slower for the first subcutaneous dose of VAQTA Adult compared with historical data for intramuscular administration. At 24 weeks following the first subcutaneous dose, the SPR was similar to the historical data at 4 weeks after the initial intramuscular dose. However, at 4 weeks following the second subcutaneous dose, the SPR was similar to the historical data 4 weeks after the second dose with intramuscular administration. Subcutaneous administration of VAQTA Adult was generally well tolerated.</p><p>&nbsp;</p><p><em>Administration</em><em> </em><em>in</em><em> </em><em>HIV-infected</em><em> </em><em>adults</em></p><p>In a clinical study with 180 adults, 60 HIV-positive (20 to 45 years of age) and 90 HIV-negative adults (21 to 53 years of age) received VAQTA Adult (50U) and 30 HIV-positive adults (22 to 45 years of age) received placebo. At 4 weeks following the first dose of VAQTA Adult, the SPR was 61% for HIV- positive adults and 90% for HIV-negative adults. At 28 weeks following the first dose (4 weeks following the second dose) of VAQTA Adult, the SPRs were satisfactory for all groups: 94% ( GMT of 1,060 mIU/mL) in HIV-positive and</p><p>&nbsp;</p><p>100% (GMT of 3,602 mIU/mL) in HIV-negative adults. Furthermore, in the HIV- positive group receiving VAQTA Adult, the SPR was 100% (GMT of 1,959 mIU/mL) in subjects with CD4 cell counts &sup3;300 cell/mm3; however, the SPR was 87% (GMT of 517 mIU/mL) in subjects with CD4 cell counts &lt;300 cell/mm3. Three HIV-positive adults with CD4 cell counts &lt;100 cells/mm3 &nbsp;did</p><p>not seroconvert after receipt of 2 doses of vaccine. The kinetics of the immune response were slower in the HIV-positive group compared with the HIV- negative group. There was an increased rate of local and systemic adverse effects reported in HIV-positive versus HIV-negative adults. In HIV-positive adults, administration of VAQTA Adult did not appear to adversely affect the CD4 cell counts and HIV RNA burden.</p><p>&nbsp;</p><p><em>Post-marketing</em><em> </em><em>safety study</em></p><p>In a post-marketing safety study, conducted at a large health maintenance organisation in the United States, a total of 29,587 individuals &sup3; 18 years of age received 1 or 2 doses of VAQTA Adult. Safety was monitored by reviewing medical records that tracked emergency room and outpatient visits, hospitalisations and deaths. There was no serious, vaccine-related, adverse event identified among the 29,587 individuals in this study. There was no non- serious, vaccine-related, adverse event resulting in outpatient visits, with the exception of diarrhoea/gastroenteritis in adults at a rate of 0.5%. There was no vaccine-related, adverse event identified that had not been reported in earlier clinical trials with VAQTA Adult.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Evaluation of pharmacokinetic properties is not required for vaccines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No preclinical safety testing was performed using the vaccine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium borate decahydrate (0.070 mg/dose)</p><p>Sodium chloride (9 mg/dose)</p><p>Water for injections ( q.s.).</p><p>&nbsp;</p><p>For adjuvant and for information regarding residual components in trace quantities, see sections 2, 4.3 and 4.4.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;C - 8&deg;C).</p><p>&nbsp;</p><p>DO NOT FREEZE since freezing destroys potency.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1 mL suspension in a pre-filled syringe (type I glass) with plunger-stopper (chlorobutyl isoprene blend).</p><p>&nbsp;</p><p>1 mL suspension in a pre-filled syringe (type I glass) with plunger-stopper (chlorobutyl isoprene blend), without needle, with a tip-cap (chlorobutyl isoprene blend), with 0, 1 or 2 separate needles.</p><p>&nbsp;</p><p>1 mL suspension in a vial (type I glass), grey rubber stopper (chlorobutyl isoprene blend).</p><p>&nbsp;</p><p>Pack sizes: Pack of 1 syringe or 1 vial.</p><p>&nbsp;</p><p>Not all pack sizes or presentations may be marketed.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The vaccine should be used as supplied; no reconstitution is necessary.</p><p>&nbsp;</p><p>Parenteral drug products should be inspected visually for extraneous particulate matter and discoloration prior to administration. After thorough agitation, VAQTA Adult is a slightly opaque white suspension.</p><p>&nbsp;</p><p>Shake well immediately before use. Thorough agitation is necessary to maintain suspension of the vaccine. For syringe without attached needle, hold the syringe barrel and attach the needle by twisting in clockwise direction until the needle fits securely on the syringe.</p><p>&nbsp;</p><p>It is important to use a separate sterile syringe and needle for each individual to prevent transmission of infections from one person to another.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorisation Holder
Merck Sharp & Dohme B.V.
Waarderweg 39, 2031 BN Haarlem, The Netherlands.

Manufacturer:
Merck Sharp & Dohme LLC.
Sumneytown Pike, P.O. Box 4, West Point, PA, USA


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dec 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>